Caligenix

Company Overview

Snapshot

Founded in August 2014 by Dr. Tzur Gabi and Eliad Josephson, Caligenix operates with 1-10 employees. The company has secured $720,000 across one funding round from one investor. In May 2021, Caligenix announced the launch of two genomic-based wellness brands, Dermatype and Biotype, focusing on personalized skincare and nutrition.

Business overview

Caligenix is a biotechnology company specializing in personalized genomic diagnostic kits. The company's core technology leverages genetic variation to understand individual dietary responses and the role of nutrients in gene expression. Caligenix offers two primary tests, the Health and Wellness test and the Sports test, each analyzing 45 genetic markers related to lifestyle aspects like weight management, nutrient metabolism, and physical activity. These tests are designed to enable B2B clients to customize health and wellness offerings based on genomic data, serving the Health Tech & Life Sciences sector, particularly in digital healthcare and digital therapeutics.

Strategic signal

In May 2021, Caligenix launched Dermatype and Biotype, two genomic-based wellness brands offering personalized skincare and nutrition products. This strategic expansion into direct-to-consumer wellness brands, leveraging AI algorithms and genomic insights, signals the company's ambition to broaden its market reach beyond B2B and capitalize on the growing demand for highly personalized health solutions, indicating a growth-positive trajectory for investors.

Company Intelligence Q&A

What is Caligenix's primary focus?

Caligenix is a biotechnology company that develops personalized genomic diagnostic kits to optimize health and fitness by understanding the link between genetic variation and individual dietary response.

When was Caligenix founded and by whom?

Caligenix was founded in August 2014 by co-founders Dr. Tzur Gabi and Eliad Josephson.

What products does Caligenix currently offer?

Caligenix currently offers two main tests: the Caligenix Health and Wellness test for general well-being and the Caligenix Sports test for enhancing athletic performance and reducing injury risk. Both tests analyze 45 genetic markers.

What was a significant product launch for Caligenix in 2021?

In May 2021, Caligenix launched two genomic-based wellness brands, Dermatype and Biotype, which offer personalized skincare and nutrition products based on individual genomic DNA.

What was Caligenix's entry into the nutritional supplement space?

In December 2020, Caligenix launched Immunotype, a DNA-based supplement designed to address the human immune system at the genomic level, marking its entry into the nutritional supplement market.